Volume 75, Issue 9 pp. 810-812

Surgical biopsy in lymphoma*

Michael Eaton

Michael Eaton

* Flinders Medical Centre, Breast and Endocrine Surgical Unit, Adelaide, South Australia and †Royal Melbourne Hospital, Clinical Haematology and Medical Oncology, Melbourne, Victoria, Australia

Search for more papers by this author
Richard Fox

Richard Fox

* Flinders Medical Centre, Breast and Endocrine Surgical Unit, Adelaide, South Australia and †Royal Melbourne Hospital, Clinical Haematology and Medical Oncology, Melbourne, Victoria, Australia

Search for more papers by this author
First published: 02 September 2005
Michael Eaton, Suite 601, Flinders Private Hospital, SA 5042, Australia.
Email: [email protected]
*

Both authors of this paper are members of the Australian Cancer Network's Working Party on the Diagnosis and Management of Lymphoma.

M. Eaton MD, FRACS; R. Fox PhD, FRACP.

Abstract

The term ‘lymphoma’ describes malignant lymphoproliferative diseases that originate from B- and T-cells in the lymphatic system. The majority of lymphomas arise from lymph nodes, while some may originate in extranodal sites. Lymphoma is a common cancer, affecting approximately 4000 people in Australia per year, and constituting 4% of newly diagnosed cancers. Lymphoma is primarily a disease of adults, and is the sixth most common cancer in men, after prostate, colorectal, lung, melanoma and bladder, and the fifth most common cancer in women, after breast, colorectal, melanoma and lung1.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.